Tag: italy

August 21, 2018

LGC Capital Shares Update from Italian Partner

LGC Capital announced its Italian partner, Evolution Bnk started planting cannabis at its facility, with the first harvest expected by October.
August 20, 2018

9 US Solar Energy Stocks

Growth in solar energy is expected to skyrocket in the US over the next several years — get ready by checking...
August 19, 2018

5 Top Weekly NASDAQ Biotech Stocks: Idera Rises to the Top

Idera Pharmaceuticals, Eiger Biopharma, Aevi Genomic Medicine, Evofem Biosciences and Biospecifics Tech were last week's top gainers on the NASDAQ...
August 12, 2018

5 Top Weekly NASDAQ Biotech Stocks: Vericel Takes Top Spot

Vericel, AcelRx, Tetraphase Pharmaceuticals, KalVista and Infinity Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
July 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: resTORbio Leads the Pack

resTORbio, ADMA Biologics, Misonix, Novus Therapeutics and Innovate Biopharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
July 15, 2018

5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top

Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ...
July 1, 2018

5 Top Weekly NASDAQ Biotech Stocks: Avid Bioservices on Top

Avid Bioservices, Arbutus Biopharma, Catalyst, ArQule and CTI BioPharma were last week's top gainers on the NASDAQ Biotechnology Index.
June 10, 2018

5 Top Weekly NASDAQ Biotech Stocks: MEI Pharma on Top

MEI Pharma, Anavex Life Sciences, Trillium Therapeutics, Celldex Therapeutics and Ophthotech were last week's top gainers on the NASDAQ Biotechnology...
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 9, 2018

miRagen Therapeutics Announces New Interim Data From Phase 1 Clinical Trial of Cobomarsen in Mycosis Fungoides

miRagen Therapeutics (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced new interim data...